Actinomyces israelii is a Gram-positive anaerobic organism commonly associated with canaliculitis in adults. Pediatric canaliculitis is relatively rare, especially in infancy. We report the case of an 11-month-old boy who presented with co-existing canaliculitis and congenital nasolacrimal obstruction. The presenting signs included epiphora, discharge, conjunctival congestion, and matting of lashes. On examination, punctual pouting, regurgitation, and yellow canaliculiths were noted. A punctoplasty and canalicular curettage were performed along with nasolacrimal probing. Microbiological tests confirmed the organisms to be A. israelii. We discuss the clinical features and management of Actinomyces-associated canaliculitis and review the available literature on pediatric canaliculitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892068PMC
http://dx.doi.org/10.4103/ijo.IJO_1075_17DOI Listing

Publication Analysis

Top Keywords

congenital nasolacrimal
8
pediatric canaliculitis
8
canaliculitis
5
actinomycetes canaliculitis
4
canaliculitis complicating
4
complicating congenital
4
nasolacrimal duct
4
duct obstruction
4
obstruction infant
4
infant actinomyces
4

Similar Publications

Objective: This study aims to determine the outcomes of probing and external dacryocystorhinostomy (exDCR) for congenital nasolacrimal duct obstruction (cNLDO) and the factors influencing the success rates in pediatric cNLDO.

Design: A retrospective sample collection was conducted at the oculoplastic referral center over 10 years (January 2012 to December 2022) for cNLDO patients who had undergone probing or exDCR.

Methodology: Data were retrospectively reviewed for patients aged ≤18 years who underwent probing or exDCR.

View Article and Find Full Text PDF

Purpose: To evaluate the role of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Serratia marcescens, and Moraxella catarrhalis in the nasal and ocular surface flora, along with their metabolic activities in children with unilateral congenital nasolacrimal duct obstruction (CNLDO).

Methods: Swabs were taken from the bilateral inferior meatus and ocular surface of 26 children with unilateral CNLDO before probing. Nasal and ocular surface swabs from non-operated eyes of children who underwent unilateral blepharoptosis or strabismus surgery formed the control group.

View Article and Find Full Text PDF
Article Synopsis
  • Congenital dacryocystoceles are uncommon birth defects linked to blocked tear ducts, presenting symptoms like excessive tearing and swelling around the eye.
  • A new minimally invasive endoscopic procedure was tested on 19 infants and young children, focusing on resecting the affected tissue without further manipulating the lacrimal duct, aiming to reduce complications.
  • The treatment was effective, with a recurrence in only two older patients, while the rest showed no issues post-surgery, suggesting this method is beneficial but may be less successful in older children with previous infections.
View Article and Find Full Text PDF

/ Congenital nasolacrimal duct obstruction (CNLDO) is commonly treated by probing, but recurrence remains a clinical issue. This study investigates the potential role of inflammatory biomarkers, such as the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR), in predicting recurrence after probing in children with CNLDO. This retrospective cohort study included 172 patients who underwent initial probing for unilateral CNLDO.

View Article and Find Full Text PDF

Background: Congenital nasolacrimal duct obstructions that persist after 9 months of age often require surgical intervention through probing and stenting of the tear duct. These procedures typically occur under general anesthesia in an operating room setting. We propose a novel approach using intravenous sedation outside the operating room.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!